Stifel Nicolaus started coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS – Free Report) in a report published on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $28.00 price objective on the stock.
Kestra Medical Technologies Trading Up 4.6 %
Shares of NASDAQ KMTS opened at $25.70 on Monday. Kestra Medical Technologies has a 12-month low of $20.00 and a 12-month high of $26.06.
About Kestra Medical Technologies
Recommended Stories
- Five stocks we like better than Kestra Medical Technologies
- What is the Hang Seng index?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- The Most Important Warren Buffett Stock for Investors: His Own
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Kestra Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kestra Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.